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ABSTRACT
Transfected cell microarray is a promising method
for accelerating the functional exploration of the
genome, giving information about protein function
in the living cell. The microarrays consist of clusters
of cells (spots) overexpressing or silencing a partic-
ular gene product. The subsequent analysis of the
phenotypic consequences of such perturbations
can then be detected using cell-based assays. The
focus in the present study was to establish an
experimental design and a robust analysis approach
for fluorescence intensity data, and to address the
use of replicates for studying regulation of gene
expression with varying complexity and effect size.
Our analysis pipeline includes measurement of
fluorescence intensities, normalization strategies
using negative control spots and internal control
plasmids, and linear regression (ANOVA) modelling
for estimating biological effects and calculating
P-values for comparisons of interests. Our results
show the potential of transfected cell microarrays
in studying complex regulation of gene expression
by enabling measurement of biological responses in
cells with overexpression and downregulation of
specific gene products, combined with the possibil-
ity of assaying the effects of external stimuli.
Simulation experiments show that transfected cell
microarrays can be used to reliably detect even
quantitatively minor biological effects by including
several technical and experimental replicates.
INTRODUCTION
The application of microarray-based technology for mole-
cule genetic analysis has revolutionized our ability to
study some aspects of gene function. DNA microarrays
have given us the possibility for high-throughput analysis
of gene expression, and thus a technology for identifying
genes that are potentially involved in particular cellular
processes as well as in physiological and pathophysiologi-
cal processes and conditions. However, DNA microarrays
do not provide a direct analysis of the functions of
the gene products within the living cell, and these func-
tional analyses are often performed on a one by one gene
basis. Ziauddin and Sabatini (1) established a method for
miniaturization of cell-based functional studies called
transfected cell microarrays. This technology allows spa-
tially restricted transfection without the use of wells by
immobilizing nucleic acids complexed with a transfection
reagent in a gel, from which it is only accessible to nearby
cells. Adherent cells growing on top of such printed spots
will take up the nucleic acids deposited in the spot, while
cells growing between the spots will not be transfected.
Ziauddin and Sabatini (1) used this system for analysis
of gene overexpression by printing cDNAs cloned in
expression plasmids. Later this method has also been
adopted for downregulation of gene expression using
siRNAs or shRNAs (2–5). Thus, this experimental setup
represents an array of collections of living cells, each over-
expressing or silencing a speciﬁc gene product. By apply-
ing appropriate assays, the phenotypic consequences
of hundreds or thousands of overexpressed or silenced
genes can be detected simultaneously. Transfected cell
microarrays have been used to identify genes involved in
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mosome segregation and nuclear structure (8), spindle
formation (4), signal transduction and transcriptional
regulation (9–12), secretory pathways (13,14), receptor
binding (1,15) and binding to antibody fragments (16).
Transfected cell microarrays have also been used to
study subcellular localization of proteins (17–20), and
can thus be applied in studies screening a large number
of genes or compounds that may aﬀect subcellular locali-
zation of given gene products.
The key advantages of all microarray technologies are
the ability to conduct easy-to-handle, high or medium
throughput studies with a small amount of reagents.
Even though transfected cell microarrays are potentially
a very powerful tool for screening and functional geno-
mics, the widespread adaption of this technology has been
relatively slow. One explanation might be that microarray
procedures generally include many steps that have to be
optimized in order to give reliable results. For transfected
cell microarrays this includes e.g. array production, trans-
fection eﬃciency, biological assays, data retrieval and
statistical analysis.
A variety of algorithms for statistical analysis of DNA
microarray high-throughput gene expression data have
been reported over the last years [reviewed in (21)]. How-
ever, development of statistical methodology for high-
throughput cell-based assays has lagged behind, and
improvements in analysis methods for this type of data
are needed. This includes the use of proper quality con-
trols of the biological assay, normalization procedures of
the data and statistical analysis protocols. Boutros et al.
(22) and Hahne et al. (23) have contributed to this task by
presenting statistical methods and software for the inter-
pretation of data from high-throughput cell-based RNAi
screens in 384-well microplates and cell-based assays with
ﬂow cytometric read-outs, respectively. In addition, statis-
tical methods for analysis of high-throughput screening in
drug discovery are under development [reviewed in (24)].
The use of transfected cell microarrays to analyse gene
functions is still in its infancy, and most of the focus has
been directed to optimization of the reverse transfection
protocol and development of diﬀerent output assays
shown as proof-of-principles. More focus is needed on
the quantitative analysis of the array-based data including
e.g. the use of controls and replicates, normalization
strategies and statistical analysis. Standardization of the
analysis of transfected cell microarray data is much
more complex than for traditional DNA microarrays.
There is a huge variety in the assay outputs from trans-
fected cell microarrays, with the possibility of measuring
many parameters per spot or per cell, and the analysis
is highly dependent on the biological assay applied. The
analysis approaches of data from transfected cell micro-
arrays can be divided into two groups depending on the
level of resolution needed (5). In assays depending on
single cell resolution, microscopes are used to acquire
high-resolution readouts. Quantitative image analysis of
ﬂuorescence intensities down on a single-cell level, and
approaches for classiﬁcation of diverse cellular pheno-
types using high-resolution images are under development
(3,8,17,25–27). When single cell resolution is not needed,
microarray scanners can be used to quickly provide a low-
resolution image of the entire slide, and quantiﬁcation of
spot intensities can be obtained using software originally
developed for traditional DNA microarray analysis (1,27).
Transfected cell microarray is a promising tool for high-
throughput screening of gene functions. However, the pos-
sibility of printing many replicate spots on one array, as
well as the possibility of multiplexing, makes it an attrac-
tive method also for more medium-scale studies addres-
sing deﬁned biological questions with fewer genes. We
have focused on the use of transfected cell microarrays
for medium-scale studies using ﬂuorescent reporters
and a laser scanner for obtaining ﬂuorescence signal inten-
sity values per spot. As has been acknowledged for
DNA microarray analysis (21) and addressed for high-
throughput screens in drug discovery (24), the inclusion
of replicates is necessary to account for both technical and
biological variation. The objective in the present study was
to establish experimental and statistical approaches to
enable a robust and reliable analysis of ﬂuorescence inten-
sity data, and to address the use of technical (replicate
spots on one array) and experimental (the independent
repetition of the reverse transfection experiment) repli-
cates for studying regulation of gene expression with vary-
ing complexity and eﬀect size. We performed three studies
(summarized in Table 1) with increasing complexity, and
with well-established biological eﬀects, using ﬂuorescent
gene reporter plasmids, siRNAs and external stimulus
treatment of cells. To deal with the replicate variation
known to occur in all biological experiments (22,28), we
used linear regression (ANOVA) modelling for estimating
biological eﬀects due to diﬀerent conditions (the nucleic
acids printed in the spots) and treatments (external stimuli
added to the cells for the induction of gene expression),
and for the calculation of P-values for comparisons of
interests. For each study we performed a simulation exper-
iment addressing the number of replicates necessary for
detecting the biological eﬀects with diﬀerent eﬀect sizes
and variable degrees of complexity of the molecular mech-
anisms studied. The use of linear regression (ANOVA)
modelling was then evaluated by comparing it with four
other analysis approaches for transfection studies.
MATERIALS AND METHODS
Plasmids and siRNAs
The expression plasmids pEGFP-N1 and pDsRed-
express-N1 were obtained from BD Bioscience Clontech.
In these plasmids, the expression of the green (EGFP) or
red (DsRed) ﬂuorescent protein is driven by a cytomega-
lovirus (CMV) promoter. Reporter plasmids with promo-
ters driven by CRE or NFkB elements were generated as
follows: The gene encoding EGFP was prepared from
pEGFP-N1 by digestion with NcoI and HpaI. The lucifer-
ase (luc) gene was removed from pCRE-Luc and pNFkB-
Luc (Stratagene) by digestion with EcoNI and NcoI
after creating a digestion site for NcoI around the start
codon using the QuickChange Site-Directed Mutagenesis
Kit from Stratagene. The fragment encoding EGFP
was inserted into the plasmids to give pCRE-EGFP
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into E.coli and isolated with Plasmid Maxi Kit (Qiagen).
Synthetic siRNA speciﬁc to EGFP (siEGFP): sense,
50-GCAAGCUGACCCUGAAGUUCAU-30; antisense,
50-GAACUUCAGGGUCAGCUUGCCG-30 (3), speciﬁc
to all ICER splice variants (siICER): sense, 50-CAUU
AUGGCUGUAACUGGATT-30; antisense, 50-UCCAG
UUACAGCCAUAAUGGG-30 (29). Control siRNA tar-
geting CAT (chloramphenicol acetyl transferase) (siCAT):
sense, 50-GAGUGAAUACCACGACGAUUUC-30; anti-
sense, 50-AAUCGUCGUGGUAUUCACUCCA-30 (3).
siEGFP and siCAT were obtained from The Biotechnol-
ogy Centre, University of Oslo (30,31), and were annealed
at 10mM(  0.14mg/ml) in 10mM Tris–HCl, pH 7.4.
siICER were obtained from Qiagen and annealed at
20mM(  0.25mg/ml) in siRNA suspension buﬀer (Qiagen).
Array printing and reversetransfection
In the present work, the protocol was based on the so-
called lipid-DNA method reported by Ziauddin and
Sabatini (1). The workﬂow includes making the printing
solution, printing the arrays, incubate cells on top of the
arrays and detect the resulting eﬀects in the spots.
(Illustrated in Supplementary Figure 1.) Below, the diﬀer-
ent steps in our version of the protocol with optimization
eﬀorts are described.
Printing solution. Several transfection reagents were
tested (data not shown), and we found that the
X-tremeGENE siRNA transfection reagent (Roche) gave
good transfection eﬃciencies both for plasmids and
siRNAs, and chose to use this reagent for all transfected
cell microarray experiments in the present study. For
printing the arrays, one major challenge is to ﬁnd a
good balance between high transfection eﬃciency and
spatially conﬁned spots to avoid cross-contamination
between the spots. In order to optimize the reverse trans-
fection protocol for HEK 293ind-ICER IIg cells (see
below) and X-tremeGENE transfection reagent, we inves-
tigated the eﬀect of varying the concentrations of gelatine
and sucrose in the printing solution. These reagents have
been reported to inﬂuence both the transfection eﬃciency
and spot integrity (6,27). Sucrose was observed to be
speciﬁcally beneﬁcial for obtaining high transfection eﬃ-
ciency when storing the arrays for several weeks before
use (data not shown). Figure 1A and B show representa-
tive images of the observed eﬀects of varying the concen-
trations of gelatine and sucrose. We observed that the
transfection eﬃciency increased with increasing gelatine
concentration (tested in the range 0.01–0.40%). However,
an increased disturbance of the spatial deﬁnition of the
spots was observed with increasing concentrations of gela-
tine or sucrose (tested in the range 0–100mM). A com-
bined eﬀect of the concentrations of gelatine and sucrose
was also observed, as low concentrations of gelatine
allowed us to use higher concentrations of sucrose than
with higher concentrations of gelatine before cells spread
outside the spots. Based on several optimizing experi-
ments, we found that 3ml X-tremeGENE solution per
microgram nucleic acid, 25mM sucrose and 0.1% gelatine
in the ﬁnal printing solution reproducibly gave spatial
restricted transfection with high transfection eﬃciency
printing the arrays with both a pipette tip and a hand-
held arrayer (see below).
In a 1.5ml microcentrifuge tube, plasmid (1mg/ml) and
siRNA were mixed with growth medium without fetal calf
serum (FCS), 0.5ml 1.5M sucrose and 3ml X-tremeGENE
per microgram nucleic acid to a ﬁnal volume of 22.5ml.
After 15–20min of incubation, 7.5ml 0.4% gelatine
(Type B, G9391, Sigma) was added to give 30ml printing
solution. The gelatine solution was prepared as described
by Ziauddin and Sabatini (1). To achieve suﬃcient level of
expression from the transfected plasmids, 25–50ng/ml
pEGFP-N1 or pDsRed-express-N1 and 50–75ng/mlo f
CRE or NFkB reporter plasmids was used. For siRNA
studies, 2–30ng/ml siRNA in the ﬁnal printing solution
was used.
Array printing. The DNA-lipid-gelatine solution was
arrayed onto UltraGAPS
TM coated slides (Corning) at
room temperature. The requirement of an expensive
robotic arrayer for printing the microarrays can be an
obstacle for many research groups to adopt this method
in their lab. For small- and medium-scale studies it is
possible to print the arrays using a small pipette tip (19),
Table 1. Studies performed on transfected cell microarrays
Studies Experimental
replicates
Conditions Treatment
(stimulus)
1. Dose siRNA
Downregulation of EGFP
using diﬀerent concentrations of siRNA
2 pEGFP+pDsRed+siEGFP (0–30ng/ml)
pEGFP+pDsRed+siCAT (30ng/ml)
pCRE-Luc (negative control)
none
2. NF B
Stimulation of reporter gene
3 pNFkB-EGFP
pNFkB-EGFP+pDsRed
pEGFP+pDsRed
pCRE-Luc (negative control)
 TNFa
a
3. ICER
Transcriptional repressor-mediated
inhibition of reporter gene
4 pCRE-EGFP+siCAT
pCRE-EGFP+siICER
pCRE-Luc (negative control)
 tetracycline
b
aActivation of promoter driving reporter gene.
bInduces gene expression of ICER transcriptional repressor.
ICER, inducible cAMP early repressor.
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type Gilson/Biohit, Sarstedt) giving spots of about
800mm in diameter (about 15 nl sample per spot). We
also used the hand-held microarrayer MicroCaster
TM
from Schleicher and Schuell, which consists of an arrayer
tool containing eight pins and a slide holder with an index-
ing system to guide the spotting of up to 768 spots, each
with a diameter of about 500mm (about 6 nl sample per
spot). For printing with the hand-held microarrayer, 15ml
of printing solution for each condition were added to wells
in a 384-well plate. The eight pins were prepared and
washed according to the manufacturer’s instructions.
After printing, the slides were dried for at least 1h in
room temperature before placed at 48C together with a
desiccant until use.
Cell line. HEK 293ind-ICER IIg cells stably transfected
with a gene encoding the ICER IIg splice variant
driven by a tetracycline-inducible promoter (29) were
used in all transfected cell microarray experiments.
The expression of ICER is at normal levels in the untreated
condition, with an overexpression of ICER IIg as a
response to tetracycline. The cells were cultured at 378C
in a humidiﬁed 5% CO2 incubator in Dulbecco’s
modiﬁed Eagle’s medium (DMEM) containing 4.5g/l
glucose (Gibco, Invitrogen) supplemented with 1% (v/v)
penicillin-streptomycin (Gibco, Invitrogen), 0.1mg/ml
L-glutamine (Gibco, Invitrogen), 150mg/ml Hygromycin
B (Invitrogen), 15mg/ml Blasticidin (Invitrogen) and 10%
FCS (Euroclone).
Reverse transfection, treatment and fixation. Immediately
before transfection, actively growing cells were trypsinized
and resuspended in growth medium to desired density.
The printed slides were placed in QuadriPERM plates
(Vivascience) and overlaid with 3 10
6cells in 8ml
medium. To be able to observe a treatment eﬀect on the
diﬀerent conditions in the spots, it is necessary to use
either two arrays or divide the array into separate wells.
When using a cell culture accessory made of silicone to
give two separate wells on the array (a modiﬁed version of
FlexiPERM from Vivascience), each of the two wells was
incubated with 1 10
6cells in 2ml medium. To stimulate
expression from CRE and NFkB reporter plasmids,
10mM forskolin (Sigma) and 20ng/ml hrTNF-a (R&D
Systems) was used, respectively. After 48h of incubation,
the slides were gently washed in PBS, and the cells were
ﬁxed (3.7% paraformaldehyde and 4% sucrose in PBS)
for 20min at room temperature. The slides were gently
washed in PBS, and the nuclei were stained by incubating
for 5min with 500ml1ml/ml DAPI (Invitrogen) in PBS per
slide. The slides were gently washed three times with PBS
before mounted with Mowiol 4-88 mounting medium pH
8.5 [6g glycerol, 2.4g Mowiol 4-–88 (Hoechst), 6ml
dH2O, 12ml Tris–HCl buﬀer pH 8.5], and placed at 48C
overnight before image acquisition.
Image acquisition, dataprocessing andstatistical analysis
The data were analysed by the following steps:
(1) Laser scanning to obtain a picture of the ﬂuorescence
intensities in the spots.
(2) Quantiﬁcation of spot intensities.
(3) Log-transformation.
(4) Normalization to negative control spots.
(5) Linear regression models to explain the transformed
and normalized ﬂuorescence intensities in each spot
based on data from more than one experimental
replicate, resulting in estimated biological eﬀects
and calculated P-values for comparisons of interests.
Scanning. Transfected cell microarrays were scanned
using Tecan’s LS Reloaded
TM scanner. The scanning
images were obtained with a 6mm resolution, and the
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Figure 1. Eﬀects of sucrose and gelatine concentrations on spot integ-
rity and transfection eﬃciency. (A) Array printed with pDsRed
(50ng/ml) in a printing solution with diﬀerent gelatine and sucrose
concentrations. Scanning image of the whole array and magniﬁcations
of speciﬁc spots. (B) Array printed with pEGFP (50ng/ml) in a printing
solution with 25mM sucrose and four diﬀerent concentrations of
gelatine. Top: Box plot of the ﬂuorescence intensities in each spot
(n=32–34). Bottom: Scanning image showing squares of seven times
ﬁve spots for the four gelatine concentrations. From left to right: 0.01,
0.05, 0.1 and 0.2% gelatine. The DNA-lipid-gelatine-sucrose solutions
were printed manually with a 10ml pipette tip (A) or by MicroCaster
TM
manual arrayer system (B).
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with wavelength 488 and 532nm, and the ﬁlters 535/25
and 575/50nm, respectively. For display, the scanning
images were pseudocoloured and the levels were adjusted
using Adobe Photoshop.
Quantification of spot intensities. Quantiﬁcation of the
level of ﬂuorescence protein expression in each spot was
performed using the GenePix software (Axon Instru-
ments, Inc., Union City, CA, USA). Brieﬂy, the mean
greyscale values were measured within circles of diameter
corresponding to 600 or 900mm in the scanning image for
arrays printed with MicroCaster
TM or a 10ml pipette tip,
respectively. Features with visual defects were eliminated
from the analysis (ﬂagged spots). The percentage of
ﬂagged spots in the three studies presented in this work
was <4%, and we did not observe any diﬀerence in the
number of ﬂagged spots printing with the 10ml pipette tip
or using MicroCaster
TM.
A ﬂuorescent microscope was used for conﬁrming
the results obtained from the laser scanner. Selected ﬂuo-
rescence microscope pictures were analysed in the open-
source image analysis software CellProﬁler (www.cellpro
ﬁler.org) (25), where the MeasureImageIntensity module
was used to quantify the total image intensity in images of
each spot. This quantiﬁcation gave similar results as
obtained using a laser scanner and GenePix software for
quantiﬁcation (an example is shown in Supplementary
Figure 2).
Log-transformation and normalization to negative control
spots. The green ﬂuorescence protein (EGFP) was used to
visualize the biological problem under study, while the red
ﬂuorescence protein (DsRed) was an internal control used
for transfection eﬃciency normalization of the EGFP
ﬂuorescence intensity in each spot. The data were
log-transformed (base 2) giving log-green or log-ratio
(log-green minus log-red) intensity signals in each spot.
The log-transformed data were normalized to the negative
control spots (i.e. pCRE-Luc) by subtracting the median
of the log-green or log-ratio intensities in the negative
control spots from all the spots printed on the same
array or in the same well on an array, i.e. as a means of
background correction on the log scale. We used the
median value as this is less inﬂuenced by outliers than
the mean value. These log-transformed and normalized
data were used further in the statistical analysis.
Plots of each experimental replicate on the original scale
were constructed by ﬁrst calculating the mean values
and the upper and lower limits ( 2SD) for the log-trans-
formed and normalized data and then transforming these
values back to the original scale.
Linear regression method. We used linear regression
models to explain the observed normalized and log-
transformed spot intensities on the basis of the diﬀerent
conditions printed on the array (diﬀerent printing
solutions with plasmids and siRNAs), the diﬀerent
treatments (external stimulus added to the cells) and
the diﬀerent independent experiments (experimental
replicates). Each condition was represented by several
replicate spots per treatment (technical replicates) in
each experimental replicate. Each study then consists of
several experimental replicates, each with several replicate
spots of each condition per treatment (technical replicates).
Let the number of experimental replicates be denoted
ne, where we assume that ne 2. Further we have one or
two treatments, nt. Denote by nc the number of conditions
for every treatment and experimental replicate, where we
assume that nc 2.
If there is only one treatment (i.e. no treatment eﬀect to
model), we ﬁt the following linear regression model:
Yikl ¼   þ ei þ ck þð ecÞik þ "ikl 1
Here Yikl is either the normalized log-green or the normal-
ized log-ratio signal in the lth spot in experimental repli-
cate i for condition k. The overall level of all spots in all
experimental replicates and for all conditions is called m.
The eﬀect of the ith experimental replicate is denoted ei,
i=1,..., ne, and the eﬀect of the kth condition is denoted
ck, k=1,...,nc. The term (ec)ik models the interaction
between experimental replicate i and condition k. Finally,
"ikl denotes the remaining unexplained variation in the
data, and we assume that "ikl is normally distributed
with mean 0 and variance s
2. We assume that this unex-
plained variation is independent between the spots. This
linear regression model is the same as a two-way ANOVA
model. For an introduction to the theory behind the linear
regression models, we refer to (32,33).
When there are two treatments we add a treatment eﬀect
tj, j=1, 2, to the previous model, and by including inter-
action terms between the treatment, experimental replicate
and condition eﬀects, the resulting model is given by
Yijkl ¼  þ ei þ tj þ ck þð etÞij þð ecÞik þð tcÞjk
þð etcÞijk þ "ijkl 2
where Yijkl is the normalized log-green or normalized log-
ratio signal in the lth spot in experimental replicate i for
treatment j and condition k. Also here we assume that the
unexplained variation, "ijkl, is independent between the
spots. This linear regression model is the same as a
three-way ANOVA model.
From the linear regression models we estimate the treat-
ment and condition eﬀects and the diﬀerence between the
diﬀerent conditions within a treatment, or the diﬀerence
between the two treatments for each condition.
In the estimation of the parameters, we use the follow-
ing sum-to-zero constraints:
Xne
i¼1 ei ¼ 0,
Xnt
j¼1 tj ¼ 0,
Xnc
k¼1 ck ¼ 0,
Xne
i¼1 ðetÞij ¼
Xnt
j¼1 ðetÞij ¼ 0,
Xne
i¼1 ðecÞik ¼
Xnc
k¼1 ðecÞik ¼ 0,
Xnt
j¼1 ðtcÞjk ¼
Xnc
k¼1 ðtcÞjk ¼ 0, and
Xne
i¼1 ðetcÞijk ¼
Xnt
j¼1 ðetcÞijk ¼
Xnc
k¼1 ðetcÞijk ¼ 0:
In a balanced design, the overall eﬀect, m, is estimated as
the overall mean of all the observations, ei is the mean of
the observations in experimental replicate i minus m, tj is
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is the mean of the observations in condition k minus m.
The estimated two and three-way interactions are esti-
mated in a similar manner. In an unbalanced design, the
estimates are slightly modiﬁed.
For each eﬀect and comparison of eﬀects of interest, we
estimate parameters based on the log-transformed and
normalized data. When results (plots, estimates) are pres-
ented on the original scale, all calculations are ﬁrst per-
formed on the log-scale and then transformed back to the
original scale.
We compare conditions within or between treatments
by testing the null hypothesis that their diﬀerence on log
scale is 0. The test statistic used is the estimated diﬀerence
between the conditions or treatments of interest divided by
the estimated standard error of this diﬀerence. The stan-
dard error is found from the covariance matrix of the
estimated eﬀects, and the test statistic is t-distributed.
The P-value is then calculated from the test statistic. An
evaluation of our linear regression method is found in the
Results and Discussion section.
All the analysis of the quantiﬁed spot intensities was
done using the free software environment for statistical
computing and graphics R. The R code is available
upon request: <mettela@math.ntnu.no>.
Simulation experiments
We performed simulation experiments in order to evaluate
the number of technical and experimental replicates neces-
sary for detecting a known biological eﬀect. Technical
replicates were removed from the dataset and P-values
for comparisons of interests were calculated based on
the resulting dataset using the linear regression method
presented above or four other analysis approaches
(methods A–D) described in the Results and Discussion
section and in Supplementary Data. The process of
removing technical replicates from the dataset was
repeated using all the experimental replicates present
and, for some experiments, all combinations of at least
two experimental replicates. The simulation experiments
performed in this study are described in detail in the
Results and Discussion section, and were performed
using the R software.
RESULTS AND DISCUSSION
Measurementof featureintensity and choice
ofnormalization strategies
Measurement of feature intensity. Biological eﬀects are
measured as exogenously expressed ﬂuorescence protein
in the cells localized in the spots of the array. It is there-
fore necessary to establish whether mean or median of the
pixel intensities in each spot is the most suitable measure
of the feature intensity representing the level of the ﬂuo-
rescent proteins. Evaluation of the distribution of pixel
intensities in six spots printed with pEGFP showed that
this distribution was skewed to the right (Figure 2A), in
agreement with what others have reported for the ﬂuores-
cence intensities in each cell within a spot (27). The ﬂuo-
rescence intensity varied substantially from pixel to pixel
within one single spot (within-spot variability). As
observed using a ﬂuorescence microscope, this corre-
sponded to a high variation in the amount of expressed
ﬂuorescence protein in each cell within one spot (data not
shown). Most of the cells expressed the ﬂuorescence
protein with intensity in the lower range, while some
cells expressed very high amounts of the ﬂuorescence
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Figure 2. Evaluation of ﬂuorescence intensities in each spot.
(A) Density plots of pixel intensities from six spots printed with
pEGFP (green lines). Mean (black lines) and median (red lines) of
the pixel intensities in each spot. The scanning image shows the
EGFP ﬂuorescence intensity signal (green) in the six spots. The pixel
intensities in each spot were acquired using the ‘Example save pixel
values’ in the Report menu in GenePix software. This resulted in a
text-ﬁle with 7884 pixel values for each spot. Plotting was done using
the R software. (B) Spot-to-spot variability in 26 spots printed with
pEGFP and pDsRed. EGFP, DsRed and ratio (EGFP normalized
to DsRed) ﬂuorescence intensity signal (mean of the pixel intensities)
normalized to the mean of the signal from all the spots. The arrays
were printed using MicroCaster
TM.
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intensities in the spots. Since these high pixel intensities
reﬂect true signals, we preferred to use the centre of grav-
ity of the pixel intensity distribution. Therefore, we used
the mean of the pixel intensities in each spot as a measure
of the feature intensity for analysis of the eﬀects of the
various conditions and treatments.
Normalization using negative control spots and internal
control plasmids. Evaluation of ﬂuorescence intensity
from spots printed with the non-ﬂuorescent reporter plas-
mid pCRE-Luc revealed that these signals were higher
than the signals from the cell layer between the spots.
Using such spots as negative (or background) controls
are valuable for the assessment of exogenous expression
of ﬂuorescence protein as spots expressing such proteins
should yield higher intensity signals. We also observed
that the intensity signal from spots printed with the non-
ﬂuorescent reporter plasmid pCRE-Luc varied between
arrays. Thus, the use of these spots to normalize the
data for diﬀerences in the global background signal on
the arrays, allow comparisons of spot intensities between
arrays. Based on these observations, spots printed with the
non-ﬂuorescent reporter plasmid pCRE-Luc were used as
negative control spots throughout the present study.
Similarly, Chang and colleagues (34) normalized the
data to a negative control.
The transfection eﬃciency varies from spot to spot, and
hence there is variability in the ﬂuorescence intensity
signal in spots printed with the same printing solution.
This spot-to-spot variance creates high variability in the
data obtained. Cotransfection with a plasmid, that gives
constitutively active expression of a ﬂuorescent protein,
can be used to normalize for this variability (2,4,10,12).
Cultivating cells on top of spots containing the two plas-
mids pEGFP and pDsRed yielded a good correlation
between the two ﬂuorescence intensities in each spot (cor-
relation factor r=0.97), and the variation in the data was
reduced by normalizing the EGFP ﬂuorescence intensity
data to the DsRed ﬂuorescence intensity data in each spot
(Figure 2B). This illustrates that an internal control plas-
mid can be valuable in order to normalize for the spot-to-
spot variability. Normalization to an internal control can
also be seen as local background normalization in each
spot.
Analysis ofdownregulation of reporter gene expression
using siRNA (DosesiRNA study)
We ﬁrst used the validated siRNA targeting EGFP
(siEGFP) (3,27) in order to apply the linear regression
model without a treatment eﬀect [Equation (1)] for
the analysis of data from two experimental replicates.
pEGFP, pDsRed and diﬀerent concentrations of
siEGFP were cotransfected and the resulting EGFP ﬂuo-
rescence was analysed with and without normalization to
DsRed in order to also evaluate the eﬀects of using an
internal control plasmid to correct for spot-to-spot varia-
tion. The setup and scanning image of the EGFP and the
DsRed ﬂuorescence intensity signal for one of the experi-
mental replicates are shown in Figure 3A.
The linear regression modelling is explained in detail by
looking speciﬁcally at the diﬀerent terms in the model for
the EGFP intensity data normalized to the DsRed inten-
sities (ratio intensities) (Figure 3B). The ﬁrst term in the
model is the overall eﬀect m (Figure 3B-a), representing the
level of all the spots in both experimental replicates.
Adding an experimental replicate eﬀect ei to the model,
explains a factor diﬀerence in the ﬂuorescence intensities
between the two experimental replicates (Figure 3B-b).
Even though each experimental replicate is performed
under presumably identical circumstances, the absolute
value of the detected ﬂuorescence signal intensities will
vary between experimental replicates, giving rise to the
experimental replicate eﬀect. The condition eﬀect ck
explains the diﬀerences between the eight conditions
printed on the arrays (Figure 3B-c). The condition eﬀect
is added to the experimental eﬀect to explain the observed
condition eﬀects in the two experimental replicates
(Figure 3B-d). However, as shown below, the data is
better described by including an interaction eﬀect between
condition and experimental replicate in the model
(Figure 3B-e). The observed data from each spot illustrates
the remaining unexplained variation in the data, "ikl. The
experimental replicate eﬀect explains the same factor dif-
ference for all conditions between experimental replicates,
which come from diﬀerences that aﬀect all conditions in
the same way. This can be a result of e.g. small diﬀerences
in cell density and scanning settings. When the interaction
eﬀect between experimental replicate and condition is
included, this opens the opportunity to manage distinct
factor diﬀerences between experimental replicates for the
various conditions. Such variations may arise from e.g.
small diﬀerences in concentrations of the constituents of
the printing solutions caused by the pipetting inaccuracy
and from variations in the printing of the diﬀerent condi-
tions onto the array. The estimated eﬀects of the k diﬀerent
conditions were then found as m+c k (Figure 3B-c), while
the estimated variance and P-values for comparisons of
interests were calculated based on the ﬁtted model in
Figure 3B-e.
The estimated eﬀect of siEGFP was a downregulation
of the EGFP ﬂuorescence of about 70–80% using
15–30ng/ml siRNA (Figure 3C). The resulting 95% con-
ﬁdence intervals for the estimated eﬀects were slightly
smaller when normalizing to the DsRed ﬂuorescence
intensities (Figure 3C, right) than when only using the
EGFP ﬂuorescence intensities (Figure 3C, left). This
shows that normalization to an internal control in each
spot reduced the variation in the data obtained. It should
be noted that when using EGFP ﬂuorescence intensities
alone, a signiﬁcant diﬀerence (P<0.01) was estimated
between no siRNA (0) and control siRNA (ctrl)
(Figure 3C, left). Using data normalized to the DsRed
internal control plasmid, the linear regression method esti-
mated no diﬀerence (P=0.98) between the two conditions
(Figure 3C, right). This further demonstrates the impor-
tance of using an internal control plasmid to correct for
possible variations in the amount of transfected plasmid
between diﬀerent conditions printed on the array.
The inclusion of both technical and experimental repli-
cates in transfected cell microarray experiments is
PAGE 7 OF 15 Nucleic Acids Research, 2008, Vol. 36, No. 15 e97Experimental replicate effects
Experimental replicate and condition
effects, with data
Experimental replicate, condition and
joint effects, with data
A
B
bc a
C
de
m m+ck
0 ng/µl
siEGFP
0 ng/µl
siEGFP
5 ng/µl
siEGFP
15 ng/µl
siEGFP
negctrl
2.5 ng/µl
siEGFP
10 ng/µl
siEGFP
30 ng/µl
siEGFP
ctrl
0
0.5
1
1.5
2
R
e
l
a
t
i
v
e
 
E
G
F
P
 
i
n
t
e
n
s
i
t
y
0
0.5
1
1.5
2
R
e
l
a
t
i
v
e
 
E
G
F
P
 
i
n
t
e
n
s
i
t
y
0 2.5 5 10 15 30 ctrl 0 2.5 5 10 15 30 ctrl
−2.5
−2
−1.5
−1
−0.5
0
0.5
1
1.5
2
l
o
g
-
r
a
t
i
o
 
i
n
t
e
n
s
i
t
y
−2.5
−2
−1.5
−1
−0.5
0
0.5
1
1.5
2
l
o
g
-
r
a
t
i
o
 
i
n
t
e
n
s
i
t
y
−2.5
−2
−1.5
−1
−0.5
0
0.5
1
1.5
2
l
o
g
-
r
a
t
i
o
 
i
n
t
e
n
s
i
t
y
0 2.5 5 10 15 30 ctrl
negctrl
−2.5
−2
−1.5
−1
−0.5
0
0.5
1
1.5
2
l
o
g
-
r
a
t
i
o
 
i
n
t
e
n
s
i
t
y
−2.5
−2
−1.5
−1
−0.5
0
0.5
1
1.5
2
l
o
g
-
r
a
t
i
o
 
i
n
t
e
n
s
i
t
y
ng/µl siRNA
0 2.5 5 10 15 30 ctrl
negctrl
ng/µl siRNA
ng/µl siRNA ng/µl siRNA
0 2.5 5 10 15 30 ctrl
negctrl
ng/µl siRNA
0 2.5 5 10 15 30 ctrl
negctrl
ng/µl siRNA
0 2.5 5 10 15 30 ctrl
negctrl
ng/µl siRNA
Overall effect
m+e1 and m+e2
Condition effects 
m+ei+ck m+ei+ck+(ec)ik
EGFP Ratio
Figure 3. Linear regression modelling without a treatment eﬀect. Cells were cotransfected with pEGFP (30ng/ml), pDsRed (30ng/ml) and diﬀerent
concentrations of siEGFP (0–30ng/ml). (A) Left diagram indicates the placement of the cell clusters for eight conditions. pEGFP, pDsRed and 0, 2.5,
5, 10, 15 or 30ng/ml siEGFP. The non-ﬂuorescent reporter pCRE-Luc (60ng/ml) as a control of the background ﬂuorescence in the spots (negctrl).
pEGFP, pDsRed and 30ng/ml siCAT as a siRNA control (ctrl). Middle diagram: Scanning image for EGFP-detection. Right diagram: Scanning
image for DsRed-detection. (B) Illustration of the diﬀerent terms in the linear regression model in Equation (1). The ratio ﬂuorescence signal
intensities (EGFP intensities normalized to DsRed intensities) from each spot (log-transformed and normalized to negative control spot intensities) in
two experimental replicates (28–35 technical replicates after removing ﬂagged spots) were used to ﬁt the model. (a) The overall eﬀect m. (b) The
overall eﬀect m and the experimental replicate eﬀects e1 and e2. (c) The overall eﬀect m and the condition eﬀects c1 through c8. (d) Combining m,e i
and ck. (e) Addition of the interaction eﬀect term (ec)ik to the terms in (d). The observed data from each spot are shown together with the ﬁtted
model in (d) and (e) for experimental replicate 1 (black circles) and experimental replicate 2 (blue triangles). (C) Estimated eﬀects of the diﬀerent
conditions are shown based on the EGFP ﬂuorescence intensity data (green, left) or the EGFP ﬂuorescence intensity data normalized to DsRed
control plasmid intensities (ratio, right). The intensities are shown relative to 0ng/ml siRNA, error bars are 95% CI. The arrays were printed using
MicroCaster
TM.
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conﬁdence. However, the inclusion of more replicates than
necessary for detecting biological eﬀects under study is a
waste of both reagents and labour time. It is therefore
important to use an experimental design optimally suited
to achieve signiﬁcant analysis results with the smallest
number of replicates possible. In order to evaluate how
many technical replicates that was suﬃcient to detect
the eﬀect of diﬀerent concentrations of siEGFP, we per-
formed a simulation experiment by randomly removing
technical replicates from each of the two experimental
replicates. Without normalization to an internal control
(Figure 4A), four technical replicates were suﬃcient to
detect signiﬁcant eﬀects of 10–30ng/ml siEGFP. Eighttech-
nical replicates resulted in a signiﬁcant eﬀect of the siRNA
for all siRNA concentrations tested in this experiment
(i.e. 2.5–30ng/ml). When using data normalized to the
internal control, two technical replicates were suﬃcient
for detecting the downregulation of EGFP for all ﬁve
siRNA concentrations tested (Figure 4B), showing again
that normalization is valuable for reducing the variation
in the data.
These experiments showed that the results were highly
reproducible using the optimized protocol for array pro-
duction. The linear regression model presented ﬁts the
observed data and is a valuable tool for analysing data
from more than one experimental replicate. Normaliza-
tion of the data to an internal control plasmid in each
spot resulted in reduced variation in data as observed by
smaller conﬁdence intervals in the estimated eﬀects and
fewer technical replicates necessary for obtaining signiﬁ-
cant eﬀects of siEGFP.
Analysis oftranscriptional induction using reporter gene
and externalstimulus (NFiBstudy)
Transfected cell microarrays can be used to study the
expression of reporter genes under various conditions,
thus enabling assaying large number of proteins of interest
for their involvement in regulation of transcription via
speciﬁc promoter elements (9–11). In such studies it is
often of interest to add a stimulus to the cells. To develop
a linear regression model suited for the analysis of eﬀects
from diﬀerent cell treatments, we created a transfected cell
microarray data set based on measurements of the stimu-
lation of NFkB (Nuclear factor-kappa B) responsive pro-
moter elements by tumour necrosis factor alpha (TNFa).
NFkB is a well-known family of transcription factors
involved in immune and inﬂammatory reactions (35),
and is known to be activated by TNFa. To include the
eﬀects of an external stimulus in the linear regression
(ANOVA) model, we added a treatment eﬀect (t) to the
model [Equation (2)].
By using this linear regression (ANOVA) model on data
from three experimental replicates, the estimated eﬀect of
TNFa on NFkB-driven transcription from pNFkB-EGFP
was a mean fold increase of 5.6 (Figure 5A).
Cotransfection of pNFkB-EGFP with pDsRed yielded a
mean TNFa stimulation eﬀect of 4.7-fold increase based
on EGFP (green) ﬂuorescence intensity data (Figure 5B).
This diﬀerence in the eﬀect of TNFa on NFkB-driven
transcription in spots with and without cotransfection
with pDsRed was not signiﬁcant (on 5% signiﬁcance
level calculated by a two-sample t-test using the Welch-
approximation to the degree of freedom). Normalizing the
EGFP ﬂuorescence with the control plasmid DsRed ﬂuor-
escence in each spot reduced the estimated mean TNFa
stimulation eﬀect to a 3.5-fold increase (Figure 5B), due to
the fact that the CMV promoter in the DsRed control
plasmid is also stimulated by TNFa. The CMV promoter
driving expression from the plasmids pEGFP and pDsRed
was stimulated by TNFa with a mean fold induction of
about 1.5 (Figure 5C). The result is not surprising since
the CMV promoter contains NFkB-binding sites (36).
Thus, pDsRed is less suitable as an internal control plas-
mid in this system. However, since the promoter in
pNFkB-EGFP was more strongly stimulated than the
CMV promoter, the stimulation eﬀect of TNFa was not
abolished using the normalized data.
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to detect the known stimulation eﬀect on NFkB-driven
transcription by TNFa, we performed a simulation experi-
ment by removing replicates from the dataset (Figure 5D).
Using only EGFP ﬂuorescence intensities and all three
experimental replicates, two technical replicates were
suﬃcient to detect a signiﬁcant eﬀect of TNFa. The ana-
lysis further demonstrates that two experimental repli-
cates were suﬃcient to identify a highly signiﬁcant eﬀect
when three technical replicates were included. For the
data normalized to DsRed ﬂuorescence intensities, two
technical replicates were suﬃcient both for three and
two experimental replicates. Thus, even though normal-
ization with DsRed weakens the estimated TNFa eﬀect,
due to TNFa–induced activation of the CMV promoter
driving DsRed expression (Figure 5B), the ability to detect
biological eﬀects is enhanced due to reduced variation
in the data.
These results showed that transfected cell microarray
with ﬂuorescent protein reporter genes can be used to
measure the eﬀect of an external stimulus treatment of
the cells. An internal control plasmid may be valuable to
reduce the variation in the data and thereby reduce the
number of replicates necessary for detecting signiﬁcant
treatment eﬀects. However, care has to be taken when
normalizing the data to an internal control plasmid as
the expression of the reporter gene from the plasmid can
be aﬀected by the treatment or the biological condition
under study.
Analysis offunction oftranscriptional repressor using
reporter gene, siRNAs and externalstimulus (ICER study)
We further wanted to evaluate whether transfected cell
microarrays and our analysis approach can be used to
study more complex biological problems with smaller
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printed with (A) pNFkB-EGFP (green ﬂuorescence intensity), (B) pNFkB-EGFP and pDsRed (green, red and ratio ﬂuorescence intensity) or
(C) pEGFP and pDsRed (green, red and ratio ﬂuorescence intensity). Fluorescence intensities relative to the TNFa-untreated condition, error
bars are 95% CI.
 P<0.01; signiﬁcant diﬀerence from TNFa-untreated cells. The arrays were printed using a 10ml pipette tip. The data from
the three experimental replicates are shown in Supplementary Figure 3. (D) Simulation of the number of technical and experimental replicates
necessary for obtaining a signiﬁcant (P<0.01) stimulation eﬀect of TNFa on NFkB-driven transcription for the condition pNFkB-EGFP cotrans-
fected with pDsRed. We removed 1, 2, 3 and 4 out of 6 technical replicates from each experimental replicate, repeated this 6, 15, 20 and 15 times,
respectively (i.e. all possible permutations containing the desired number of spots), ﬁtted the linear regression model in Equation (2) based on the
resulting dataset, and recording the proportion of P-values below 0.01 for the eﬀect of TNFa on NFkB-driven transcription. This was performed for
all three experimental replicates and all combinations of two experimental replicates, and for both EGFP ﬂuorescence intensity data (green, left) as
well as for data after normalization with DsRed (ratio, right).
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described in this work. By use of luciferace reporter plas-
mids in a 96-well plate format, Misund et al. (29) have
shown that overexpression of inducible cAMP early
repressor splice variant IIg (ICER IIg) represses CRE-
driven but not NFkB-driven transcription. ICER is tran-
scribed from an intronic CRE-driven promoter (P2) in the
cAMP responsive element modulator (CREM) gene, and
functions as an eﬀective repressor of CRE-mediated tran-
scription, both its own and other cAMP responsive genes
(37). (Illustrated in Supplementary Figure 4).
Since ICER may be involved in negative feed-back
responses associated with growth regulation and tumori-
genesis (38–41), it is of great interest to identify ICER
target genes and molecular mechanisms involved in acti-
vating and modulating ICER repressing eﬀects.
Transfected cell microarrays may represent an attractive
platform to test a high number of hypotheses related to
such questions by using CRE-driven ﬂuorescent protein
reporter genes.
ICER-mediated repression of forskolin-induced CRE-
driven transcription on transfected cell microarrays
was assayed as reduced activation of the reporter plasmid
pCRE-EGFP in cells overexpressing ICER IIg.
Overexpression of ICER IIg was induced in HEK293ind-
ICER IIg cells by tetracycline (29). pCRE-EGFP was
co-spotted with either a control siRNA targeting CAT
(siCAT) or siRNA targeting ICER (siICER) in order to
control that the transcriptional repression was indeed
caused by ICER. The siICER used was shown in separate
experiments to give a speciﬁc down-regulation of ICER
IIg expression both in a luciferase fusion reporter plasmid
assay and in western blot (data shown in Supplementary
Figure 4). An internal control plasmid was not used, as the
CMV promoter in pDsRed contains CRE elements (36),
and thus is expected to be regulated by the same activating
and repressing molecular event as pCRE-EGFP. In pre-
liminary experiments the eﬀect we were looking for was
observed to be smaller than the eﬀects detected in the two
previous studies. We, therefore, printed 36 technical repli-
cates, and four experimental replicates were performed. In
each of the experimental replicates, similar relative diﬀer-
ences between the signals measured at the diﬀerent condi-
tions and treatments were observed, but the eﬀect of
ICER IIg overexpression was small and the variation in
the data was large (Figure 6A, left). When the linear
regression (ANOVA) model in Equation (2) was used to
estimate the eﬀect of ICER IIg overexpression based on all
the data (Figure 6A, right), it could be shown that over-
expression of ICER IIg (+tet) resulted in a signiﬁcant
(P<0.01) downregulation in CRE-driven EGFP expres-
sion of about 30%. In the presence of siICER, this repres-
sing eﬀect was reduced and was no longer signiﬁcant
(P=0.11), illustrating that the observed eﬀect was,
indeed, caused by ICER IIg. A control experiment was
performed showing that overexpression of ICER IIg
(+tet) had no repressing eﬀect on NFkB-driven transcrip-
tion (Figure 6B).
A simulation experiment was then performed in order
to evaluate the number of technical and experimental
replicates necessary to detect the repressing eﬀect of
ICER IIg on CRE-driven transcription. The eﬀect of
ICER IIg overexpression on CRE-driven transcription
was still signiﬁcant (P<0.01) for all combinations of
three and two experimental replicates when all technical
replicates were included in the analysis (data not shown).
However, removing technical replicates from the dataset
resulted in a reduced chance of obtaining a signiﬁcant
eﬀect of ICER IIg overexpression on CRE-driven tran-
scription (Figure 6C). The simulation experiment indi-
cated that we might have to include more than twelve
technical replicates and three to four experimental repli-
cates in order to detect the eﬀect of ICER IIg overexpres-
sion on CRE-driven transcription on transfected cell
microarrays using the experimental setup presented here.
Evaluation ofthe linear regression method
In order to evaluate the use of our linear regression
(ANOVA) models, we assessed the value of including
the interaction eﬀects in the models, and compared our
analysis method with four other possible analysis
approaches.
Interaction effects. The inclusion of interaction eﬀects
between experimental replicate and condition, between
experimental replicate and treatment, and between experi-
mental replicate, treatment and condition, will not inﬂu-
ence the estimates of the eﬀect sizes, but will provide
improved estimates of the variability of the estimated
eﬀect sizes. For the three studies analysed we have com-
pared the full model (all interaction eﬀects included) with
a reduced model (only marginal eﬀects and interaction
eﬀect between condition and treatment included). We
used a likelihood ratio test (42) to investigate the null
hypothesis that the reduced model provides an equally
good description of the data as the full model. The follow-
ing results were found: in the analysis of the Dose siRNA
study we ﬁtted the model with and without the interaction
eﬀect of the condition and experimental replicate. The
inclusion of this interaction eﬀect gave a signiﬁcant
improvement to the model (P=3E-53). For the NFkB
study we compared the full model (all interaction eﬀects
included) with the model where only the marginal eﬀects
and the interaction eﬀect of treatment and condition were
present, and found the full model to be superior to the
reduced model (P=3E-8). The same was found for the
ICER study (P=1E-13). This means that by including
the interaction eﬀects in our models, we are able to pro-
vide a better description of the data than without the
interaction eﬀects.
Comparison with other analysis approaches. One common
way to present data from biological assays is to show
results from only one representative experimental repli-
cate, even though the experiment has been repeated with
similar results several times. Statistical analysis is thus
performed using data from that experimental replicate
alone. However, this results in loss of informative data
and a potential selection bias. Using the data from all
experimental replicates in the statistical analysis will give
a more robust and objective analysis.
PAGE 11 OF15 Nucleic Acids Research, 2008, Vol. 36, No. 15 e97The linear regression method was compared with four
other analysis approaches (denoted methods A–D), which
may be used for analysing ﬂuorescence intensities on
transfected cell microarrays based on data from all experi-
mental replicates. We used the data from the ICER study,
and looked at the eﬀect size of ICER IIg overexpression
(treatment with +tet) as compared to endogenous ICER
IIg expression (treatment with –tet) on CRE-driven EGFP
expression, and calculated the P-values for this
comparison using the diﬀerent methods. The data used
in the statistical analysis for methods A–D are:
  Method A: Mean spot values for each condition and
treatment from each experimental replicate.
  Method B: Mean spot values for each condition and
treatment normalized to the mean of the unstimulated
state (endogenous ICER expression) for each condi-
tion in each experimental replicate.
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Figure 6. Linear regression modelling with a treatment eﬀect for analysis of transcriptional repression. (A) Eﬀect of ICER IIg overexpression on
forskolin-stimulated CRE-driven transcription. Duplicate arrays with spots printed with pCRE-EGFP (50ng/ml) together with siCAT or siICER
(25ng/ml), and negative control spots (pCRE-Luc, 50ng/ml) were overlaid with HEK293ind-ICER IIg cells. The cells on one of the two arrays were
treated with 1mg/ml tetracycline (tet) for 20h before ﬁxation to induce overexpression of ICER IIg, and both arrays were stimulated with 10mM
forskolin 6h before ﬁxation to induce CRE-driven expression. The EGFP ﬂuorescence intensities are expressed relative to tetracycline untreated state
for four experimental replicates (left). Mean 2SD (33–36 technical replicates after removing ﬂagged spots). The resulting estimated eﬀect of each
condition and treatment based on all the data using the linear regression model in Equation (2) (right). Error bars are 95% CI.
 P<0.01; signiﬁcant
diﬀerence from tetracycline-untreated cells. (B) Eﬀect of ICER IIg overexpression on TNFa-stimulated NFkB-driven transcription. The experiment
was performed as in A, with pCRE-EGFP substituted by pNFkB-EGFP, and stimulation with TNFa (20ng/ml) instead of forskolin. EGFP
ﬂuorescence intensity relative to the tetracycline-untreated state estimated from three experimental replicates using the linear regression model in
Equation (2). Error bars are 95% CI (24–36 technical replicates). The arrays were printed using a 10ml pipette tip. (C) Simulation of the number of
technical and experimental replicates necessary for obtaining a signiﬁcant (P<0.01) eﬀect of ICER IIg overexpression on CRE-driven transcription.
We randomly removed 6, 12, 18, 24 and 30 out of 36 technical replicates in each experimental replicate, used the resulting datasets to ﬁt the linear
regression model in Equation (2), calculated the P-values for the eﬀect of ICER IIg overexpression for the condition pCRE-EGFP cotransfected with
siCAT, repeated this 1000 times and recorded how many times the P-value was below 0.01. This was done for all four experimental replicates and all
combinations of three and two experimental replicates.
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replicates.
  Method D: Spot values from all experimental replicates
normalized to the mean of the unstimulated state for
each condition in each experimental replicate.
Methods A and B are two possible simpliﬁed strategies
that only use mean values from each experimental repli-
cate for estimating the eﬀect size and calculating P-values.
Method B diﬀer from method A in that it includes a nor-
malization step to achieve fold change values for each
experimental replicate in order to correct for potential
diﬀerences in absolute values that are often seen between
experimental replicates (scale factor between the measured
values in diﬀerent experimental replicates on original
scale). P-values for methods A and B are calculated
using a two-sample two-sided t-test based on these
means per experimental replicate and treatment for each
condition separately. Methods C and D diﬀer from meth-
ods A and B in that they include the variation in the
technical replicates in the analysis by using all spot
values, instead of only the mean values, from each experi-
mental replicate as input to a two-sample, two-sided t-test
to produce P-values. Method C simply uses all spot values
from all experimental replicates, while in method D each
spot value is ﬁrst normalized to correct for diﬀerences in
absolute values between the experimental replicates.
For a mathematical description of the diﬀerent methods
we refer to Supplementary Data.
For all methods, the linear regression method and meth-
ods A–D, the estimated eﬀect size (fold change) is approxi-
mately the same. The methods diﬀer in the calculations of
the estimated uncertainty of the estimated eﬀect sizes,
which is visible in the calculated P-values for the test
that the log eﬀect size equals zero, presented in Table 2.
When we used method A or B we did not detect a signiﬁ-
cant eﬀect of ICER IIg overexpression on CRE-driven
expression (P>0.05) while, based on other studies (29),
we expect ICER IIg overexpression to result in repression
of CRE-driven expression. Analyses using methods C, D
and the linear regression method, revealed a signiﬁcant
treatment eﬀect of ICER IIg overexpression. We also
compared the ﬁve methods by performing simulation
experiments addressing the level of signiﬁcance for the
eﬀect of ICER IIg overexpression on CRE-driven tran-
scription when removing technical replicates from the
dataset (Figure 7, left). Using the mean-based methods
(methods A and B), removing technical replicates from
the dataset did still not give any signiﬁcant eﬀect of
ICER IIg overexpression. The linear regression method
and methods C and D detected the repressing eﬀect
equally well even if 18 out of 36 technical replicates were
removed from each experimental replicate. However, with
fewer technical replicates, the linear regression method
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Figure 7. Evaluation of ﬁve diﬀerent analysis methods by simulation experiments. From the ICER study data, we randomly removed 6, 12, 18, 24
and 30 out of 36 technical replicates in each of four experimental replicates, and used the resulting datasets to calculate P-values for the eﬀect of
ICER IIg overexpression using diﬀerent analysis methods. For each analysis method, this was repeated 1000 times, and the number of P-values
below 0.01 was recorded. The graphs show the eﬀect on CRE-driven transcription for pCRE-EGFP cotransfected with siCAT (left), and pCRE-
EGFP cotransfected with siICER (right).
Table 2. Estimated eﬀect size and P-values for the eﬀect of ICER IIg overexpression compared to endogenous ICER IIg overexpression on CRE-
driven EGFP-expression calculated using ﬁve diﬀerent methods (LM, A, B, C, D)
Condition Estimated eﬀect size
a P-values
LM
b A
c B
c C
c D
c
pCRE-EGFP+siCAT 0.71 5E-10 0.20 0.06 8.4E-7 4.4E-8
pCRE-EGFP+siICER 0.92 0.11 0.51 0.34 0.14 0.14
aOn original scale.
bLM, Linear regression method described in Materials and Methods section (Equation 2).
cMethods A–D are described mathematically in Supplementary Data.
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the presence of siICER, as expected, none of the analysis
methods gave a signiﬁcant eﬀect of ICER IIg induction on
CRE-driven transcription (Table 2 and Figure 7, right).
These results show the importance of including all avail-
able data in the analysis when aiming at detecting small
biological eﬀects. The linear regression method and the
methods using all spot values in the analysis detected the
small biological eﬀect of ICER IIg overexpression on
CRE-driven EGFP expression, where the mean-based
methods could not. In addition, when reducing the
number of technical replicates in the dataset, the linear
regression method was shown to detect the small biologi-
cal eﬀect more often than methods C and D. This is due to
a reduced variation in the estimated eﬀects using the linear
regression method. While methods C and D only use the
information in one condition at a time for estimating the
variation in the data, the linear regression method uses the
whole dataset.
CONCLUDING REMARKS
Transfected cell microarray is a versatile, eﬃcient and
cost-reducing technology (43) that can contribute to
further understanding of gene functions and regulatory
mechanisms governing gene expression by enabling mea-
surements of biological responses in cells with overexpres-
sion or downregulation of speciﬁc gene products
combined with the possibility of assaying eﬀects of exter-
nal stimuli. We showed the importance of including a
suﬃcient number of replicates and of using all available
data in the statistical analysis in order to reliably detect
biological eﬀects. Simulation experiments may be valuable
for estimating the number of replicates necessary for
detecting biological eﬀects of interest, based on data
from positive and negative controls for the assay being
performed. As the analysis of transfected cell microarrays
is in its infancy, no state-of-the-art coherent statistical
methodology is currently established. Our linear regres-
sion (ANOVA) models have the advantage of providing
the research community with a general framework that
enables simultaneous use of measurements from all spots
and all experimental replicates in a study. Our method
takes into account both marginal and interaction eﬀects
of treatment, condition and experimental replicate, and
reports valid estimates of eﬀect sizes, i.e. fold changes,
and signiﬁcance thereof.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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